← Back to Search

Behavioural Intervention

SMP Program with Standard Care for Juvenile Idiopathic Arthritis

N/A

Recruiting

Research Sponsored by University of Calgary

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Adolescents between the ages of 12 and 17

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

Study Summary

This trial aims to test a virtual self-management program for adolescents with JIA across different provinces. Participants will be divided into two groups - one group will participate in the program while the other group will receive

Who is the study for?

This trial is for adolescents with Juvenile Idiopathic Arthritis (JIA) who are interested in a virtual program to help manage their condition. Participants should be willing to attend online group sessions and complete certain health measures before and after the program.Check my eligibility

What is being tested?

The study is testing a Virtual Self-Management Program (SMP) that includes disease education, self-management strategies, and peer support over eight weeks, compared to standard care without this additional support.See study design

What are the potential side effects?

Since there's no medical intervention like drugs or surgery involved in this trial, traditional side effects aren't expected. However, participants may experience discomfort from discussing personal health issues in a group setting.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 12 and 17 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Intervention fidelity

Program Adherence Rates (feasability)

Satisfaction of Program

Secondary outcome measures

How Prepared the patient feels for Adult Care

Physical Pain Level

Quality of Life

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: SMP Program with Standard CareExperimental Treatment1 Intervention

four 60-90 minute virtual educational sessions over 8 weeks with a group of 4-6 participants

Group II: Standard Care OnlyActive Control1 Intervention

Standard of care(no formal education program similar to SMP) and placed on 8-week waitlist for optional intervention.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of AlbertaOTHER

889 Previous Clinical Trials

385,077 Total Patients Enrolled

University of CalgaryLead Sponsor

792 Previous Clinical Trials

869,054 Total Patients Enrolled

University of TorontoOTHER

690 Previous Clinical Trials

1,019,543 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the upper limit of participant enrollment for this medical study?

"Indeed, the information provided on clinicaltrials.gov affirms that this trial is actively seeking participants. The study was initially posted on December 13th, 2023 and underwent its most recent update on December 14th, 2023. To complete the trial successfully, a total of 100 individuals are being recruited from one designated location."

Answered by AI

Is it possible for me to participate in this research investigation?

"To be eligible for participation in this clinical trial, candidates must have a diagnosis of juvenile idiopathic arthritis and fall within the age range of 12 to 17. The study aims to recruit approximately 100 participants."

Answered by AI

What are the main goals that this clinical trial aims to achieve?

"In this clinical trial, the primary outcome will be measuring Program Adherence Rates (feasibility) over a 3-month period. Secondary outcomes include assessing Understanding of Arthritis Self-Efficacy using The Children's Arthritis Self-Efficacy Scale, evaluating Physical Pain Level with The PROMIS Pediatric Pain Interference Scale for children aged 8-17, and examining Quality of Life utilizing The Pediatric Quality of Life Inventory 3.0 Rheumatology Teen Module specifically designed for children aged 13-18 to assess their health-related quality of life in relation to pediatric rheumatology."

Answered by AI

Are individuals who are over the age of 80 eligible to participate in this medical study?

"To participate in this research study, patients must be between the ages of 12 and 17. It is noteworthy that there are a total of 60 clinical trials available for individuals under the age of 18, while there are 320 studies tailored specifically for those aged over 65 years old."

Answered by AI

Are individuals still able to enroll in this research study at the moment?

"Indeed, according to the information available on clinicaltrials.gov, this ongoing clinical trial is actively seeking eligible candidates. The study was initially posted on December 13th, 2023 and its most recent update occurred on December 14th, 2023. The trial aims to enroll a total of 100 participants from a single designated site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Virtual Self-Management Program for JIA

2023. "Virtual Self-Management Program for JIA". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06184100.

All > Juvenile Idiopathic Arthritis